FDA Approved: TRIPTODUR — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TRIPTODUR (triptorelin) from Azurity Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Precocious Puberty
• Endometriosis
• Prostate Cancer

Drugs mentioned

• TRIPTODUR (triptorelin)

Snippet

SUPPL AP for TRIPTODUR (TRIPTORELIN)